Atrium Medical Corporation Sustainability Profile
Atrium Medical Corporation, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1981, the company has established itself as a leader in the development of innovative solutions for vascular access, wound care, and surgical procedures. With a strong presence in North America and expanding operations globally, Atrium Medical is dedicated to enhancing patient outcomes through its advanced product offerings. The company’s core products include a range of catheters, drainage systems, and surgical mesh, all designed with a focus on safety and efficacy. Atrium Medical's commitment to quality and innovation has earned it a notable position in the market, recognised for its contributions to improving healthcare practices. With a history of key milestones, Atrium continues to push the boundaries of medical technology, ensuring it remains at the forefront of the industry.
DitchCarbon Score
How does Atrium Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Atrium Medical Corporation's score of 89 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Atrium Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Getinge AB (publ), and any emissions data or climate commitments may be inherited from this parent organisation. As part of its climate strategy, Atrium Medical Corporation aligns with the sustainability initiatives of Getinge AB, which has set various reduction targets and commitments. However, specific reduction targets or achievements for Atrium Medical Corporation itself have not been disclosed. The absence of detailed emissions data and specific climate pledges indicates that Atrium Medical Corporation may still be in the process of establishing its own distinct climate commitments, while potentially following the broader initiatives set by Getinge AB. In summary, while Atrium Medical Corporation is part of a larger corporate family with sustainability goals, it currently lacks specific emissions data and individual climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 6,351,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 22,687,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | 00,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Atrium Medical Corporation's Industry?
How Carbon Intensive is Atrium Medical Corporation's Location?
Atrium Medical Corporation's Scope 3 Categories Breakdown
Atrium Medical Corporation's Scope 3 emissions, which decreased by 5% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 58% of Scope 3 emissions.
Top Scope 3 Categories
Atrium Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Atrium Medical Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
